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Regulation of breathing is critical to our capacity to accommodate deficits in oxygen 
availability and demand during, for example, sleep and ascent to altitude. Key to this 
are two reflex responses, hypoxic pulmonary vasoconstriction (HPV), which aids 
ventilation-perfusion matching at the lungs, and the hypoxic ventilatory response 
(HVR) which accelerates ventilation. In 2004 I proposed that HPV might be mediated 
by the AMP-activated protein kinase, which governs cell autonomous metabolic 
homeostasis. Pharmacological evidence was presented in support of this view, and the 
hypothesis extended to incorporate a role for AMPK in regulating carotid body afferent 
input responses during hypoxia and thus the HVR. The present article reviews our 
subsequent findings on these matters and those of others, which provide strong support 
for the view that AMPK mediates HPV. AMPK is also critical to the HVR, but against 
our expectations it is not required for carotid body activation during hypoxia. Contrary 
to current consensus in this respect, our findings suggest that AMPK deficiency blocks 
the HVR at the level of the brainstem, even when afferent input responses from the 
carotid body are normal. We have therefore revised our hypothesis on the HVR, now 
proposing that AMPK integrates local hypoxic stress at defined loci within the 
brainstem respiratory network with an index of peripheral hypoxic status, namely 
afferent chemosensory inputs. Nevertheless, in general outcomes are consistent with 
the original hypothesis, that the role of AMPK has evolved, through natural selection, 
to extend to the regulation of breathing, and thus oxygen and energy (ATP) supply to 
the whole body. 
 
Introduction 
The mechanisms of hypoxia-response coupling remain keenly debated topics, nowhere 
more so than with respect to hypoxic pulmonary vasoconstriction (HPV) which aids 
ventilation-perfusion matching at the lungs, and the hypoxic ventilatory response 
(HVR) which increases breathing rates to compensate for reductions in O2 supply. In 
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2001 I developed the hypothesis (Evans, 2004) that the AMP-activated protein kinase 
(AMPK) might contribute to hypoxia-response coupling, in the context of hypoxic 
pulmonary vasoconstriction (HPV). This proposal was founded on the assertion that 
mitochondria of O2-sensing cells are uniquely responsive to hypoxia due to their 
selective expression of a specialised form of cytochrome C oxidase (COX), the kinetics 
of which were predicted to be exquisitely sensitive to changing PO2 within the 
physiological range (Mills and Jobsis, 1970, 1972). Importantly, in developing my 
hypothesis I also accounted for the findings of Leach and co-workers, who identified 
little or no evidence of a fall in cellular ATP within pulmonary arterial myocytes using 
P-NMR spectroscopy (Leach et al., 2000). Accepting the mitochondrial hypothesis on 
O2-sensing, the only obvious explanation for there being no fall in ATP availability 
during hypoxia was that any initial fall in ATP supply and associated ADP 
accumulation would be immediately compensated for by the adenylate kinase reaction, 
leading to consequent increases in the AMP/ATP ratio (Dzeja and Terzic, 2003; 
Panayiotou et al., 2014). Coincidentally there was a growing understanding of the 
significance of the AMP-activated protein kinase (AMPK) to cell-autonomous 
metabolic homeostasis, studies having revealed that AMPK is coupled to mitochondrial 
metabolism through its exquisite sensitivity to changes in cellular AMP/ATP and 
ADP/ATP ratios, and acts to maintain ATP supply in the longer term  (Hardie et al., 
1998). It was immediately apparent that, being a serine threonine kinase, AMPK might 
also phosphorylate targets outside of those canonical pathways by which it regulates 
cell-autonomous metabolic homeostasis. At this time the only way to test my 
hypothesis was through pharmacological intervention, by activating AMPK directly 
using AICAR (Corton et al., 1995) and indirectly through mitochondrial inhibition 
using the biguanide phenformin (Hawley et al., 2003). Our preliminary investigations 
were encouraging, AICAR inducing constriction of pulmonary arteries and mimicking 
precisely the effects of hypoxia in this respect. I then elaborated on my initial 
hypothesis (Evans, 2006a, b), proposing that, through natural selection, the role of 
AMPK in regulating metabolic homeostasis might have been extended to incorporate 
system-level control of ventilatory responses during hypoxia, and thus oxygen and 
energy (ATP) supply to the whole body. This raised the possibility that AMPK 
deficiency or excess might contribute to hypoxic pulmonary hypertension and sleep 
apnoea (Evans, 2006b). The aim of the present article is to review recent progress.  
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The AMP-activated protein kinase  
AMPK is a cellular energy sensor that acts to maintain energy homeostasis (Figure 1). 
It exists as heterotrimers comprising one of two catalytic α subunits, in combination 
with one each of two β and three  regulatory subunits, which together may form at 
least 12 different heterotrimeric subunit combinations (Hardie, 2014a; Hardie, 2014c). 
Evidence is now emerging in support of the view that different subunit combinations 
may be selected by a given cell type, that each combination may exhibit different 
sensitivities to activation by AMP and ADP and thus metabolic stresses, and that each 
may selectively phosphorylate and regulate a different spectrum of target proteins (Ross 
et al., 2016b). These possibilities formed the central pillars of my hypothesis regarding 
system-level control of whole-body metabolic homeostasis through AMPK (Evans, 
2006a).   
There are four nucleotide binding sites (CBS repeats) on the γ subunit, of which only 
sites designated 1, 3 and 4 may ever be occupied (Ross et al., 2016b). Binding of AMP 
to the γ subunit causes a 10-fold increase in AMPK activity by allosteric activation, 
with further activation of up to 100-fold generated by binding of either AMP or ADP 
through their promotion of phosphorylation and inhibition of dephosphorylation at 
Thr172 on the α subunit (Figure 1). Each of these effects is opposed by ATP (Gowans 
et al., 2013; Ross et al., 2015). Thr172 is primarily phosphorylated by the tumour 
suppressor kinase LKB1, which appears to be constitutively active but phosphorylates 
AMPK more rapidly when AMP and/or ADP is bound to the γ subunit, due to reduced 
dephosphorylation at Thr172 (Hawley et al., 2003; Ross et al., 2016a; Sakamoto et al., 
2004). There is also an alternative Ca2+-dependent activation mechanism, mediated 
through the calmodulin-dependent protein kinase CaMKK2 (Hawley et al., 2005; 
Woods et al., 2005), which phosphorylates Thr172 and thus activates AMPK in an 
AMP-independent manner (Hardie, 2007; Hardie, 2014a; Hardie, 2014c, d). Contrary 
to previous proposals (Emerling et al., 2009), however, there is little evidence to 
support the view that AMPK is directly activated by reactive oxygen species (ROS), 
although ROS may activate AMPK indirectly by inhibiting mitochondrial oxidative 
phosphorylation and increasing AMP/ATP and ADP/ATP ratios (Auciello et al., 2014; 
Hawley et al., 2010a). Once activated the classical action of AMPK is to phosphorylate 
targets that switch off non-essential anabolic processes that consume ATP and switch 
on catabolic pathways that generate ATP (Hardie, 2007), thereby compensating for 
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deficits in ATP supply via, for example, reductions in mitochondrial oxidative-
phosphorylation.  
Intriguingly, in the context of the present discussion, evidence suggested that the genes 
encoding the α and γ subunits of the AMPK ortholog of yeast Saccharomyces cerevisiae 
(SNF1 and SNF4) support colony level metabolic adaptations (Celenza and Carlson, 
1986; Celenza et al., 1989; Mitchelhill et al., 1994; Woods et al., 1994). For example, 
in a high glucose environment yeast initially grow rapidly using glycolytic metabolism 
to generate ATP, but when glucose runs low the growth rate slows as yeast undergo 
diauxic shift towards greater reliance on mitochondrial oxidative-phosphorylation. This 
adaptation to deficits in substrate supply can be blocked in yeast with snf1 or snf4 
mutations (Celenza and Carlson, 1986; Celenza et al., 1989; Haurie et al., 2003), 
rendering these mutants incapable of growing without a source of glucose. In an 
evolutionary context, this observation raised the possibility that natural selection may 
have extended the role of AMPK from cell-autonomous metabolic homeostasis to 
system level adaptations employed by animals to accommodate deficits in O2 and thus 
energy supply to the whole body.  
Furthermore, as noted above, the fact that AMPK is a serine threonine kinase suggested 
the capacity for regulation of processes outside of metabolism such as ion channel 
activity (Figure 1), which our findings (Evans et al., 2005c; Ikematsu et al., 2011; Ross 
et al., 2011) and those of others have since confirmed. For example, AMPK may 
phosphorylate and “inactivate” the pore forming alpha subunit of multiple Ca2+-
activated potassium channels (KCa1.1 and KCa3.1) (Klein et al., 2009; Ross et al., 2011), 
the voltage-gated potassium channel Kv1.5 (Andersen et al., 2015; Mia et al., 2012; 
Moral-Sanz et al., 2016) and the ATP-inhibited KATP channel (Kir6.2) (Chang et al., 
2009), or may phosphorylate and “activate” Kv2.1 alpha subunits (Ikematsu et al., 
2011). Thereby AMPK has the potential to increase or decrease cell excitability, in a 
manner determined by both the cell-specific expression of its subunits and members of 
the ion channel superfamily, providing the capacity for system-level adjustments to 
whole-body metabolic status (Evans, 2006a). Expanding on this, evidence is emerging 
that AMPK may also directly phosphorylate and regulate enzymes key to transmitter 
biosynthesis (Zhang et al., 2018), receptors (Ahmadi and Roy, 2016), pumps and 
transporters (Schneider et al., 2015). 
 
 5 
AMPK and hypoxic pulmonary vasoconstriction 
HPV is initiated by airway hypoxia rather than by vascular hypoxaemia (Bergofsky et 
al., 1968), through the constriction of pre-capillary resistance arteries coordinated by 
signalling pathways that are intrinsic to their smooth muscle and endothelial cells (Dipp 
et al., 2001; Evans et al., 2005a; Gaine et al., 1998; Robertson et al., 2001), and in a 
manner independent of blood-borne mediators or the autonomic nervous system 
(Naeije et al., 1989; Robin et al., 1987). The initiation phase of acute HPV is primarily 
driven by smooth muscle constriction (Dipp et al., 2001), with a threshold PO2 ≈80 
mmHg (Dipp and Evans, 2001), after which the magnitude of HPV increases with the 
degree of hypoxia. It is now generally accepted that HPV relies on the modulation of 
mitochondrial metabolism by hypoxia, the overriding question has been how? 
Recent investigations have demonstrated that NADH dehydrogenase (ubiquinone) 1 
alpha subcomplex, 4-like 2 (NDUFA4L2) (Tello et al., 2011) and cytochrome C 
oxidase subunit 4 isoform 2 (COX4I2) (Fukuda et al., 2007; Huttemann et al., 2001), 
two nuclear encoded atypical subunits of the mitochondrial electron transport chain, are 
constitutively expressed under normoxia not only by pulmonary arterial myocytes 
(Aras et al., 2013; Huttemann et al., 2012) but also by oxygen-sensing carotid body 
type I cells (Zhou et al., 2016). By contrast, in a variety of other cell types NDUFA4L2 
and COX4I2 expression is ordinarily low, but may be increased during prolonged 
hypoxia (Fukuda et al., 2007; Huttemann et al., 2001). This led to the proposal that 
constitutive expression of NDUFA4L2 and COX4I2 in O2-sensing cells might 
determine the affinity of their mitochondria for O2 and thus confer, in part, the capacity 
of these cells to monitor changes in arterial O2 supply. Accordingly it has been shown 
that HPV is occluded by deletion of the gene encoding mitochondrial protein COX4I2 
(Sommer et al., 2017), confirming the predictions of Mills and Jobsis regarding not 
only the site but also the mechanism by which hypoxia impacts O2-sensing cells (Mills 
and Jobsis, 1970, 1972). This is evident from the fact that allosteric modulation of COX 
is delivered by COX4 in a subtype-specific manner, COX4I1 but not COX4I2 
conferring COX inhibition by ATP (Horvat et al., 2006; Huttemann et al., 2001). 
Consequently, in pulmonary arterial myocytes and carotid body type I cells the rate of 
O2 consumption and thus ATP supply via mitochondrial oxidative phosphorylation will 
not increase during hypoxia as ATP levels fall (Aras et al., 2013; Fukuda et al., 2007; 
Horvat et al., 2006; Kocha et al., 2015), promoting the adenylate kinase reaction and 
consequent increases in the AMP/ATP ratio (Dzeja and Terzic, 2003; Panayiotou et al., 
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2014). It is also notable that expression of both NDUFA4L2 and COX4I2 may act to 
limit mitochondrial ROS production during hypoxia, by reducing the activity of 
complex I and COX, respectively (Fukuda et al., 2007; Huttemann et al., 2001). This is 
significant because it is evident that COX4I2 deletion (Sommer et al., 2017) may 
attenuate HPV by blocking hypoxia-evoked increases in mitochondrial ROS and/or 
cytoplasmic AMP/ATP ratios. All things considered, perhaps the latter of the two is the 
most likely to be compromised. This is a critical point because it has been argued that 
ROS may activate AMPK directly through an AMP- and LKB1-independent 
mechanism (Emerling et al., 2009), although it is most likely that ROS activate AMPK 
indirectly by inhibiting mitochondrial oxidative-phosphorylation (Auciello et al., 2014; 
Hawley et al., 2010a). 
Consistent with a role for mitochondria in HPV, all mitochondrial inhibitors tested thus 
far mimic the effects of hypoxia on pulmonary arterial smooth muscle cells at the level 
of the “oxygen-sensitive” delayed rectifier potassium (KV) current (Firth et al., 2008; 
Post et al., 1992). Curiously, however, studies on perfused lungs and pulmonary artery 
rings have shown that only some mitochondrial inhibitors constrict pulmonary arteries 
and occlude further constriction during hypoxia, while others block HPV without first 
inducing constriction (Leach et al., 2001; Weissmann et al., 2003). In this respect it is 
important to note that HPV fails under near anoxic conditions (< 1% oxygen), i.e., there 
is a PO2 window within which pulmonary artery constriction may be initiated by 
hypoxia. It is therefore notable, for example, that the NAD(P)H/NAD(P)+ ratio in dorsal 
root ganglion neurons, which do not serve to monitor oxygen supply, exhibits no shift 
until the PO2 falls to near anoxic levels (~5 mmHg); i.e., the PO2 at which HPV begins 
to fail (Dipp et al., 2003). Why might this be significant? Strictly speaking, it is the 
“anoxic” and not the “hypoxic” condition that mitochondrial inhibitors would mimic at 
concentrations that ablate oxidative-phosphorylation. Therefore, an explanation for the 
inconsistency of outcome with respect to the effects of mitochondrial inhibitors on HPV 
and the pO2 window within which HPV is triggered, may ultimately be provided by a 
greater understanding of the impact on pulmonary vascular function of degrees of 
metabolic stress. After all, opposing pulmonary vasoconstriction during anoxia might 
well serve to maximise gaseous exchange within the lungs in extremis.  
These considerations bring us back nicely to AMPK, which is activated by all 
mitochondrial inhibitors and thus hypoxia, in a manner dependent on the degree of 
inhibition of mitochondrial oxidative-phosphorylation (Hawley et al., 2010b). It is quite 
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possible, however, that during more extreme metabolic stress, such as anoxia, AMPK 
may play its now classical role and “switch off” non-essential ATP-consuming 
processes in order to ensure cell survival, and may not under these conditions function 
itself to drive constriction. Alternatively, there may simply be insufficient ATP 
availability during anoxia to allow for continued phosphorylation and activation of 
AMPK.  
What of the evidence supporting a role for AMPK in HPV (Figure 1)? Our initial studies 
(Evans et al., 2005a) showed that exposure of pulmonary arterial smooth muscle to 
hypoxia (15-20 mmHg) precipitates an increase in the cellular AMP/ATP and 
ADP/ATP ratios, concomitant activation of AMPK and phosphorylation of acetyl-CoA 
carboxylase (ACC; an established marker for AMPK action), despite the fact that 
cellular ATP levels remain remarkably stable in the presence of hypoxia (Leach et al., 
2000). Moreover, inhibition of mitochondrial oxidative phosphorylation by phenformin 
(Owen et al., 2000) evoked increases in NAD(P)H autofluorecence, AMPK activation 
and ACC phosphorylation in pulmonary arterial smooth muscle cells (Evans et al., 
2005b). AMPK activation and ACC phosphorylation were also induced by AICAR, 
which activates AMPK directly rather than by inhibiting the mitochondrial electron 
transport chain, through uptake into cells and subsequent metabolism to the AMP 
mimetic, ZMP (AICAR monophosphate; (Corton et al., 1995). Regardless of their 
respective mechanism of action, phenformin and AICAR induced an increase in the 
intracellular Ca2+ concentration in acutely isolated pulmonary arterial smooth muscle 
cells and did so by mobilising sarcoplasmic reticulum (SR) stores via ryanodine 
receptors, as does hypoxia. Most significantly, AMPK activation by AICAR evoked a 
slow, sustained and reversible constriction of pulmonary artery rings; an action not 
mimicked by phenformin due to confounding effects on smooth muscle function 
(Evans, unpublished observation).  Moreover, the sustained phase of HPV and 
pulmonary artery constriction in response to AICAR exhibited strikingly similar 
characteristics, namely: (1) A requirement for smooth muscle SR Ca2+ release via 
ryanodine receptors that is retained, if attenuated, after removal of extracellular Ca2+; 
(2) Ca2+ influx into and vasoconstrictor release from the pulmonary artery endothelium 
(Evans et al., 2005b). Consistent with these findings, HPV was also inhibited by the 
non-selective AMPK antagonist Compound C (Robertson et al., 2008), although any 
action of this agent should be considered with caution because in a screen of 70 protein 
kinases Compound C was shown to inhibit at least ten other kinases more potently than 
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AMPK (Bain et al., 2007).  
Further significant support for our original proposals has now been gathered by use of 
more selective small molecule activators of AMPK, A769662 (Goransson et al., 2007; 
Rajamohan et al., 2015) and Compound 13 (Hunter et al., 2014)), and activated 
(thiophosphorylated) recombinant human AMPK heterotrimers (Ross et al., 2011). 
Intracellular dialysis of activated human AMPK or extracellular application of AMPK 
activators resulted in phosphorylation and inhibition of recombinant KV1.5 channels 
expressed in HEK293 cells, the archetypal O2-sensing K+ channel expressed by 
pulmonary arterial myocytes (Post et al., 1992). Most significantly,  A769662 and 
Compound 13 not only inhibited KV currents in acutely isolated pulmonary arterial 
smooth muscle cells, but occluded further inhibition of these K+ currents by hypoxia 
and mitochondrial poisons (Moral-Sanz et al., 2016). Therefore, AMPK activation 
mimics the effects of hypoxia on pulmonary arterial smooth muscle cells at the 
molecular, cellular and system level.  
This leaves us with perhaps the most important question – is the LKB1-AMPK 
signalling cascade necessary for HPV?  Our preliminary studies on mice in which either 
LKB1 (Stk11), CaMKK2 (Camkk2), AMPK-1 (Prkaa1) or AMPK-2 (Prkaa2) have 
been deleted or knocked down are entirely consistent with this view (Moral-Sanz et al., 
2015; (Moral-Sanz et al., 2018).  
 
AMPK and the HVR 
As mentioned above, a natural extension of my hypothesis on the role of AMPK in 
reflex responses to hypoxia was to incorporate the HVR, and explore whether AMPK 
might be of general importance to system-level coordination of O2 supply.  At the time 
the general consensus was that the carotid bodies, the primary peripheral arterial 
chemoreceptors of mammals, govern the entire ventilatory response to falls in arterial 
PO2 (Prabhakar, 2000). Our preliminary investigations into the role of the LKB1-
AMPK signalling pathway appeared entirely consistent with this view, in that 
pharmacological studies suggested that the AMPK agonist AICAR (Corton et al., 1995) 
activated carotid body type I cells and increased afferent discharge from isolated carotid 
bodies (Evans et al., 2005b; Wyatt et al., 2007). These actions were also inhibited by 
the AMPK antagonist Compound C (Wyatt et al., 2007).  Consistent with this, 
conditional deletion of the gene encoding LKB1 virtually abolished the capacity for 
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carotid body afferent fibre discharge during hypoxia and attenuated the HVR (Evans, 
2012; Mahmoud et al., 2015a). Contrary to these findings and against our expectations, 
however, AMPK-1/2 deletion failed to attenuate afferent discharge from the carotid 
body, yet conferred even greater attenuation of the HVR (Mahmoud et al., 2015b) than 
LKB1 deletion (unpublished).  
How did the contraindications provided by our pharmacological studies arise? As 
mentioned previously, Compound C is a very non-selective kinase inhibitor, which in 
a screen of 70 protein kinases was shown to inhibit at least 10 other kinases more 
potently than AMPK (Bain et al., 2007). Moreover off target effects of other 
pharmacological tools have also been identified, such as inhibition by AICAR of 
adenosine transporters (Gadalla et al., 2004), which would raise extracellular adenosine 
concentrations, activate type I cell adenosine receptors and thus increase afferent 
discharge from the carotid body (Murali and Nurse, 2015). We attempted to cover for 
this possibility by completing some experiments using AICAR in the presence of the 
adenosine receptor antagonist 8-P-(sulphophenyl)-theophylline, but this strategy may 
have been less successful than we presumed at the time (Wyatt et al., 2007). 
Alternatively, AICAR-mediated reductions in the adenylate pool and ATP (Hasenour 
et al., 2014; Lantier et al., 2014) could similarly impact type I cell activities. Whatever 
the explanation, it is clear that AMPK is not necessary for type I cell activation during 
hypoxia. Accordingly, recent studies on the actions of two different AMPK activators, 
AICAR and A769662, suggest that these agents neither precisely mimic the effects of 
hypoxia on, nor induce pronounced activation of carotid body type I cells (Buckler, 
2015; Kim et al., 2014), and our own further investigation now supports this view 
(Evans, unpublished). 
Nevertheless, we have inadvertently uncovered a split in the dependency on LKB1 and 
AMPK, respectively, of carotid body activation during hypoxia on the one hand and 
the HVR on the other. The reasons for this remain to be resolved, but experimental 
outcomes perhaps point to hierarchical control of the respiratory network by LKB1, 
AMPK and perhaps one or more of the 12 AMPK-related kinases; unlike AMPK, the 
activities of AMPK-related kinases are in general regulated through their degree of 
expression and constitutive phosphorylation by LKB1, which occurs independent of 
cellular metabolic status, but may in some cases impact cell-autonomous metabolic 
homeostasis (Lizcano et al., 2004). Given that afferent discharge is, in great part, 
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triggered by exocytotic release of ATP from type I cells (Murali and Nurse, 2016), it is 
quite plausible that LKB1 may maintain, in an AMPK-independent manner, the 
capacity for ATP synthesis and / or exocytosis within type I cells, and thus afferent 
discharge from the carotid body. In keeping with this, studies on other cell types suggest 
that LKB1 may govern glucose homeostasis (Koh et al., 2006; Shaw et al., 2005) and 
mitochondrial function (Gan et al., 2010; Gurumurthy et al., 2010) independent of 
AMPK, either directly or through constitutive phosphorylation of an AMPK-related 
kinase (Choi et al., 2015; Lizcano et al., 2004; Patel et al., 2014). Supporting this, LKB1 
deletion has been shown to decrease mitochondrial membrane potential and basal ATP 
levels in certain cell types (Gan et al., 2010; Gurumurthy et al., 2010; Swisa et al., 
2015). Likewise, carotid body type I cells lacking LKB1 may be unable to sustain 
appropriate cellular energy charge and activity due to defective mitochondrial function, 
either at rest or during exposure to metabolic stresses such as hypoxia.  
This takes us back to ATP, ADP and AMP levels and the inhibition during hypoxia of 
type I cell K+ channels, which ultimately triggers exocytosis (Delpiano and Hescheler, 
1989; Lopez-Barneo et al., 1988; Stea and Nurse, 1991). The principle players in this 
respect are the large conductance voltage- and Ca2+-activated K+ current (BKCa) 
(Hescheler et al., 1989; Peers, 1990) and the voltage-independent TASK-like leak K+ 
current (Buckler, 1997; Kim et al., 2009; Ortega-Saenz et al., 2010); although it should 
be noted that variations in channel expression may confer identified species differences 
(Lopez-Lopez et al., 1993; Perez-Garcia et al., 2004) and contribute to changes of O2 
sensitivity during postnatal maturation (Hatton et al., 1997; Wasicko et al., 2006). It is 
now clear that hypoxia (and hypercapnia) principally acts to depolarise type I cells by 
inhibiting TASK1/3 K+ channels (Buckler, 2015), leading to Ca2+ entry through 
voltage-gated Ca2+ channels, consequent exocytosis and ATP release. Moreover, in the 
absence of a determining role for AMPK (Kim et al., 2014; Mahmoud et al., 2015b), 
evidence now supports the view that TASK K+ channels directly monitor the adenylate 
pool (Varas et al., 2007), closing when ATP levels fall consequent to the inhibition by 
hypoxia of mitochondrial oxidative phosphorylation (Wyatt and Buckler, 2004). 
AMPK does however phosphorylate and, like hypoxia, inhibit BKCa channels of carotid 
body type I cells (Ross et al., 2011), the archetypal O2-sensing K+ channel (Lopez-
Barneo et al., 1988; Peers, 1990). This action will clearly have functional consequences 
with respect to transmitter release, conceivably by modulating action potential firing 
patterns (Duncan et al., 2015), which may impact Ca2+ influx under certain conditions 
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(Evans et al., 2005b; Kim et al., 2014). However, these matters remain to be resolved. 
Nevertheless, it is clear from our own findings that all pathways key to carotid body 
type I cell activation during hypoxia must be, in some way, dependent on the continued 
expression of LKB1, but not AMPK, and a sufficiency of mitochondrial function and / 
or ATP supply. So how can both LKB1 and AMPK deletion block the HVR, when 
deletion of the latter does not adversely affect carotid body activation during hypoxia 
(Evans, 2012; Mahmoud and Evans, 2012; Mahmoud et al., 2015b)?  
It is quite plausible that peripheral chemosensors are not the sole arbiters of the HVR, 
as has been suggested by investigations on the evolution of ventilatory control systems, 
most notably with respect to the demonstration that O2-sensing occurs and a component 
of the HVR arises at the level of the caudal brainstem in amphibians, with both the 
location and influence of the primary peripheral chemosensors changing during the 
ascent from gill breathing tadpole to lung-assisted, air breathing adult (Jia and 
Burggren, 1997; Porteus et al., 2011). In fact one could reasonably argue that 
evolutionary pressures have periodically led to the reconfiguration of peripheral 
chemoreceptor inputs (Porteus et al., 2011) about a common ancestral hypoxia-sensor 
within the caudal brainstem, that underpins signal integration and thus acts as the 
“gatekeeper” of respiratory adjustments during hypoxia.  
While the aforementioned findings run counter to the view that increased afferent 
discharge from carotid body to brainstem alone determines the ventilatory response to 
a fall in arterial PO2, they do provide substantial support for an alternative yet inclusive 
perspective, namely that the HVR is determined by the coordinated action of the carotid 
body and an hypoxia-responsive circuit within the brainstem (Curran et al., 2000; Evans 
et al., 2016; Gourine and Funk, 2017; Mahmoud et al., 2015b; Smith et al., 1993; 
Teppema and Dahan, 2010). To date little emphasis has been placed on the role of 
hypoxia-sensing at the level of the brainstem, perhaps because the HVR is so effectively 
abolished by resection of the carotid sinus nerve in humans (Wade et al., 1970). Yet 
brainstem hypoxia induces an HVR when in receipt of normoxic carotid body afferent 
inputs (Curran et al., 2000; Smith et al., 2010), and directly activates (Roux et al., 2000) 
subsets of neurons within the nucleus tractor solitarius (NTS) (Pascual et al., 2002) and 
rostral ventrolateral medulla (Nolan and Waldrop, 1993; Sun et al., 1992; Sun and Reis, 
1993; Teppema and Dahan, 2010). This may in turn be supported by direct activation 
during hypoxia of lactate and / or ATP release from astrocytes (Angelova et al., 2015; 
Gourine and Funk, 2017; Magistretti and Allaman, 2018; Marina et al., 2013). 
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Moreover and consistent with the fact that our gene deletion strategy targeted 
catecholaminergic neurons (ectopic expression aside), extensive investigations have 
demonstrated that following carotid body resection, hypoxia-responsive 
catecholaminergic neurons of the caudal brainstem may underpin partial recovery of 
the HVR in a variety of animal models (Roux et al., 2000; Roux and Villard, 2010; 
Smith and Mills, 1980). Accordingly, dysfunction of these neurons has been shown to 
underpin hypoventilation and apnoea associated with Rett syndrome, which is 
exacerbated during hypoxia (Roux and Villard, 2010). Adding to this, it is evident that 
COX4I2 may, as for carotid body type I cells and pulmonary arterial myocytes, be 
expressed under normoxia by certain CNS neurons (Horvat et al., 2006), perhaps 
rendering mitochondrial oxidative phosphorylation within such cells exquisitely 
sensitive to falls in local PO2 within the physiological range. AMPK activation in a 
specialised subset of brainstem catecholaminergic neurons could thus be triggered 
during hypoxia, supporting the delivery of increased respiratory drive required to 
protect against hypoventilation and apnoea. Evidence of this was provided by 
examination of brainstem function in AMPK-1/2 knockout mice by functional 
magnetic resonance imaging (fMRI), which identified reductions in oxygen 
consumption during hypoxia (indicative of reduced activation) within discrete dorsal 
and ventral nuclei of the caudal brainstem, despite the fact that carotid body afferent 
input responses were retained (Mahmoud et al., 2015b). This has been corroborated by 
analysis of immediate early gene (cfos) expression. The caudal location relative to 
Bregma of the dorsal active region is consistent with areas of the NTS (Figure 2) that 
are activated during hypoxia and which represent the primary site of receipt of carotid 
body afferent input (Guyenet, 2000; Hirooka et al., 1997; King et al., 2012; Koshiya 
and Guyenet, 1996; Teppema and Dahan, 2010). Here AMPK-1/2 deletion may 
attenuate the activation during hypoxia of C2 adrenergic and/or A2 nor-adrenergic 
neurons proximal to the midline and the area postrema (Mahmoud et al., 2015b). 
Significantly, A2 neurons of the area postrema / NTS provide afferent inputs to and 
determine, together with the carotid body, activation by hypoxia of A1/C1 neurons 
within the ventrolateral medulla (Alheid et al., 2011; Hirooka et al., 1997), the position 
of which (Alheid et al., 2011) aligns well with the ventral active region identified by 
fMRI analysis (Mahmoud et al., 2015b); by contrast projections of the NTS mostly 
avoid key components of the rCPGS (Alheid et al., 2011), namely the Bötzinger and 
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pre-Bötzinger complexes (Smith et al., 1991).  
Our findings therefore suggest that the HVR is attenuated by loss of AMPK function at 
the level of the caudal brainstem, within a neuronal circuit spanning the C2/A2 neurons 
of the NTS and A1 neurons of the ventrolateral medulla. This is consistent with 
optogenetic and pharmacological interventions at the level of the NTS (King et al., 
2012; Yamamoto et al., 2015), and the proposal that NTS neurons lie on the sensory 
side of the central respiratory network (Aicher et al., 1996; Vardhan et al., 1993). 
Surprisingly, we observed pronounced right-left asymmetry of brainstem activation 
during hypoxia, which may provide for specialisation sufficient to prevent delays in 
respiratory responses to hypoxic stress by limiting conflicting outputs from each side 
of the brain (Vallortigara et al., 1999), as has been proposed previously with respect to 
cognitive performance (Dadda et al., 2009). Further investigation will be required to 
determine how right-left asymmetry may be orchestrated by the complex interplay of 
neurotransmitters deployed during hypoxia and the role of AMPK in such processes of 
selection. In this respect it is notable that both C2 and A2 neurons are both 
catecholaminergic and glutamatergic (Stornetta et al., 2002; Vardhan et al., 1993), and 
that 6-10% of TH-positive C2, A2 and A1 neurons also express neuronal nitric oxide 
synthase, which supports the HVR by synthesizing NO (Gozal et al., 1997) and/or S-
nitrosothiols (Lipton et al., 2001), and in a manner that may be facilitated by AMPK 
(Murphy et al., 2009). 
It could be argued that AMPK-1/2 deletion in catecholaminergic cells simply leads 
to the failure of central integration and transduction of peripheral chemoafferent inputs 
and consequent failure of the HVR, due to the inability of affected neurons to maintain 
appropriate levels of activity when exposed to metabolic stress (Culmsee et al., 2001). 
However, following AMPK-1/2 deletion carotid body afferent discharge remained 
exquisitely sensitive to falls in PO2 and ventilatory responses to hypercapnia remained 
unaffected even during severe (8%) hypoxia. Given that AMPK-1/2 deletion would 
have occurred in all catecholaminergic neurons irrespective of location and whether or 
not they are O2- or CO2-sensitive, these findings indicate that AMPK-1/2 deficiency 
does not block the HVR by compromising, per se, the capacity during hypoxia for 
activation of chemosensory catecholaminergic neurons, exocytosis nor effective 
delivery of increased respiratory drive. Rather, outcomes suggest that AMPK-1/2 
deficiency may in some other way selectively interfere with the integration and onward 
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relay of afferent input responses at the level of the NTS. This is consistent with the 
observation that neuronal integrity during hypoxia may be preserved, in part, by 
AMPK-independent mechanisms (Cheng et al., 2011) that maintain ATP supply by 
accelerating glycolysis in a manner supported by mobilisation of astrocyte glycogen 
stores (Almeida et al., 2004) and lactate release (Magistretti and Allaman, 2018). 
AMPK must therefore support the modulation by hypoxia of discrete nuclei within the 
caudal brainstem that deliver increased drive to breathe via neural networks that 
modulate the respiratory central pattern generators (rCPGs) (Guyenet, 2014), and 
which may also coordinate functional hyperaemia (Bucher et al., 2014). Whatever the 
mechanism it is most likely neurogenic and highly localised, given that AMPK 
deficiency in smooth muscles does not affect the HVR or systemic arterial blood 
pressure regulation during hypoxia, while the latter but not the former remains 
unaltered following AMPK deletion in catecholaminergic neurons (MacMillan and 
Evans, 2018). Given that AMPK-1/2 deficiency in catecholaminergic neurons 
precipitates apnoea during hypoxia and respiratory failure under anaesthesia 
(Mahmoud et al., 2016), we cannot entirely rule out the possibility that suppression of 
the HVR may be allied to exacerbation of the “Cushing reflex” (Guyenet, 2000; Paton 
et al., 2009); classically, the Cushing reflex refers to the induction of systemic 
hypertension, bradycardia and apnoea consequent to intracranial hypertension. 
However, the Cushing reflex is only elicited under anaesthesia and by ischemic hypoxia 
(~1% O2), and is maintained or enhanced by hypercapnia (Guyenet, 2000; Harris et al., 
1998; Paton et al., 2009). By contrast, hypoxic ventilatory depression was evident in 
conscious AMPK-1/2 knockouts during mild or severe hypoxia, as were deficits in 
brainstem activity, and this was reversed rather than exacerbated by hypercapnia.  
If this AMPK-dependent, hypoxia-responsive nucleus does indeed exist, why has it not 
been located before? Perhaps we are dealing with an interdependent circuit mechanism, 
with multiple points of signal integration. In this context and in light of all things above, 
we need now consider why:  
1. The degree of block by AMPK-1/2 deletion of the HVR is increased in a 
manner directly related to the severity of hypoxia (Mahmoud et al., 2015b);  
2. The HVR can be triggered by CNS hypoxia alone, providing there is continued 
receipt of basal (normoxic) afferent input from the carotid bodies (Smith et al., 
2010);  
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3. The HVR may be blocked by interference at any point within this circuit, e.g., 
by carotid body resection (Wade et al., 1970) or AMPK-1/2 deletion (Mahmoud 
et al., 2015b).  
To account for these points, we proposed that LKB1-AMPK signalling pathways 
support coincidence detection and thus signal integration at either a single node or 
multiple nodes within and thus activation of a hypoxia-responsive circuit that 
encompasses, at the very least, C2/A2 neurons within the NTS and ventrolateral A1 
neurons (Evans et al., 2016), due to the capacity for: (1) AMPK activation by increases 
in AMP/ATP and ADP/ATP ratios, and LKB1 (Hardie, 2014b) determined by “local 
hypoxic stress” (decreased ATP supply); (2) Augmentation of this response by “applied 
metabolic stress” (increased ATP usage) due to the further activation of these neurons 
through afferent inputs from peripheral chemoreceptors to the NTS (Figure 2). In turn 
this may impact ventrolateral A1 neurons and perhaps additional downstream aspects 
of the cardiorespiratory network. Afferent input and brainstem hypoxia could thereby 
determine, each in part, the set-point about which AMPK and thus the brainstem 
respiratory networks are activated during hypoxia. To test this hypothesis further, we 
must first identify the hypoxia-responsive nuclei within the brainstem and in doing so 
determine whether this nucleus incorporates adrenergic (C2) and/or nor-adrenergic 
(A2) neurons. Thereafter we may examine the relative contributions made by AMPK-
dependent modulation of cellular metabolism (Hardie, 2014b), ion channels and thus 
neuronal firing frequency (Ikematsu et al., 2011), and transmitter release (Lipton et al., 
2001; Murphy et al., 2009) to efferent outputs that deliver increased drive to breathe.  
Whether we consider HPV or the HVR, it would appear that it is AMPK-1 but not 
AMPK-2 that is critical to reflex responses during hypoxia (see for example 
(Mahmoud et al., 2016)), although AMPK-2 may play a supporting role during severe 
hypoxia. This is significant and brings us back to evolution, because investigations of 
others on high-altitude, Andean populations suggest that the gene encoding AMPK-1 
(PRKAA1) has been influenced by natural selection through single nucleotide 
polymorphisms (Bigham et al., 2014). 
 
AMPK sleep apnoea and pulmonary hypertension  
The significance of evolutionary action on AMPK-1 may lie in the fact that pulmonary 
hypertension (Lahm et al., 2014) and sleep disordered breathing (Chau et al., 2012) are 
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associated with ascent to altitude (Ainslie et al., 2013). In short, it may be beneficial to 
insure against aberrant expression of AMPK-1.  
This is evident from our finding that AMPK-1deficiency in catecholaminergic cells 
precipitates late hypoxic ventilatory depression culminating in apnoea rather than 
hyperventilation, reminiscent of the HVR of neonates (Gozal, 2016). Furthermore, 
hypoxic ventilatory depression due to AMPK deficiency in catecholaminergic neurons 
is enhanced under anaesthesia, ultimately leading to respiratory failure (Mahmoud et 
al., 2016). Thus AMPK-1 deficiency is strongly indicated in the pathogenesis of sleep 
apnoea syndrome, where management of anaesthesia is also critical (Boushra, 1996). 
In the context of pulmonary hypertension, however, we meet a paradox, because while 
AMPK-1 may drive HPV and thus acute hypoxic pulmonary hypertension, recent 
investigations of our own (unpublished since 2016) and others suggest that AMPK 
deficiency may promote pulmonary hypertension (Omura et al., 2016; Zhang et al., 
2018). Future investigations will determine how AMPK can be both friend and foe. 
 
Summary    
A growing body of evidence now supports the proposal that AMPK is key to O2 and 
thus energy (ATP) supply to the body as a whole, through its contribution to the 
governance of ventilation-perfusion matching at the lung and the HVR. Aberrant 
AMPK expression or activity may therefore compromise system responses to hypoxia, 
precipitating pulmonary hypertension (Lahm et al., 2014) and sleep disordered 
breathing (Chau et al., 2012). Notably, pulmonary hypertension and sleep disordered 
breathing are associated not only with ascent to altitude (Ainslie et al., 2013) but 
metabolic syndrome-related disorders such as obesity and type 2 diabetes (Chau et al., 
2012; Vgontzas et al., 2005), which are in turn associated with cell-specific changes to 
AMPK expression patterns (Ruderman et al., 2013). Further investigations into the role 
of AMPK in the regulation of ventilatory and vascular function in health and disease 
are therefore warranted.  
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Figure 1. AMPK and hypoxic pulmonary vasoconstriction. Schematic shows the 
mechanism by which increases in the cellular AMP/ATP and ADP/ATP ratios may 
activate 12 AMPK heterotrimeric subunit combinations, leading to target 




Figure 2. Circuit mechanism by which LKB1 and AMPK may confer hierarchical 
control of the hypoxia-responsive respiratory network. Schematic presents a 
minimal model describing the integration of carotid body afferent input responses with 
local hypoxia by brainstem respiratory networks. NTS = nucleus tractus solitarius.  
 
